Quinn Anthony
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Quinn Anthony. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| SYRE | Purchase | 10,000 | $10.00 | $100,000 | Apr 12, 2016 | |
| 0000911326 | EVP, CMO, & Head of R&D | Disposition | 27,000 | — | — | Jun 22, 2015 |
| 0000911326 | EVP, CMO, & Head of R&D | Award / Grant | 27,000 | — | — | Jun 5, 2015 |
| 0000911326 | EVP, CMO & Head of R&D | Option Exercise | 10,000 | $1.70 | $17,000 | Apr 27, 2015 |
| 0000911326 | EVP, CMO & Head of R&D | Sale | 10,000 | $108.00 | $1,080,000 | Apr 21, 2015 |
| 0000911326 | EVP, CMO & Head of R&D | Sale | 10,000 | $105.00 | $1,050,000 | Apr 15, 2015 |
| 0000911326 | EVP, CMO & Head of R&D | Option Exercise | 10,000 | $0.95 | $9,500 | Apr 6, 2015 |
| 0000911326 | EVP, CMO & Head of R&D | Sale | 700 | $71.96 | $50,372 | Sep 2, 2014 |
| 0000911326 | EVP, CMO & Head of R&D | Award / Grant | 71 | $54.89 | $3,897 | Jun 30, 2014 |
| 0000911326 | EVP, CMO & Head of R&D | Sale | 3,529 | $83.50 | $294,672 | Apr 1, 2014 |
| 0000911326 | EVP, CMO & Head of R&D | Option Exercise | 10,000 | $0.95 | $9,500 | Apr 1, 2014 |
| 0000911326 | EVP, CMO & Head of R&D | Award / Grant | 192 | $36.30 | $6,970 | Dec 31, 2013 |
| 0000911326 | SVP, Chief Medical Officer | Award / Grant | 297 | $35.68 | $10,597 | Jun 28, 2013 |
| 0000911326 | SVP, Chief Medical Officer | Sale | 9,447 | $50.08 | $473,106 | Jan 18, 2013 |
| 0000911326 | SVP, Chief Medical Officer | Option Exercise | 353 | $0.95 | $335 | Jan 17, 2013 |
| 0000911326 | SVP, Chief Medical Officer | Sale | 1,100 | $50.00 | $55,000 | Jul 27, 2012 |
| 0000911326 | SVP, Chief Medical Officer | Option Exercise | 1,900 | $0.95 | $1,805 | Jul 20, 2012 |
| 0000911326 | SVP, Chief Medical Officer | Sale | 26,000 | $40.65 | $1,056,900 | Jun 25, 2012 |